US2013345270A1PendingUtilityA1
Methods of treating cancer and other disorders
Est. expiryNov 12, 2030(~4.3 yrs left)· nominal 20-yr term from priority
A61K 31/42C07D 231/56A61K 31/416C07D 261/20
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Active compounds useful for inhibiting fatty acid synthase in a subject in need thereof are described. The active compounds are, in general, a 5-mercapto-1H-Indazole-4,7-dione or an analog thereof. The compounds are useful for treating subjects afflicted with, cancer, obesity, diabetes, a viral infection, a bacterial infection, a fungal infection, or a protozoal infection.
Claims
exact text as granted — not AI-modified1 . A method of reversibly or irreversibly inhibiting fatty acid synthase in a subject in need thereof, comprising administering to said subject an active compound as described herein in a treatment-effective amount; wherein said active compound is an 5-mercapto-1H-Indazole-4,7-dione or an analog thereof.
2 . The method of claim 1 , wherein said subject is afflicted with cancer.
3 . The method of claim 1 , wherein said subject is afflicted with obesity.
4 . The method of claim 1 , wherein said subject is afflicted with diabetes
5 . The method of claim 1 , wherein said subject is afflicted with a viral infection.
6 . The method of claim 1 , wherein said subject is afflicted with a bacterial infection.
7 . The method of claim 1 , wherein said subject is afflicted with a fungal infection.
8 . The method of claim 1 , wherein said subject is afflicted with a protozoal infection.
9 . The method of claim 1 , wherein said active compound is selected from the group consisting of compounds of Formula Ia, Ib and Ic, or pharmaceutically acceptable salts or prodrugs thereof:
where:
each Z is independently selected from the group consisting of N, O, S and CH 2 ;
A is O (then R 3 is null) or N
n=1-5; m=1-5; j=1-4
E is N, CH or CH 2 ;
R 1 , R 2 , R 3 , R 4 , and R 5 individually can represent H, lower straight-chain alkyl (e.g. alkyl groups containing one to ten carbon atoms, such as methyl, ethyl or hexyl) or branched chain lower alkyl, aromatic (e.g. phenyl, naphthyl) substituted aromatic, heteroaromatic (e.g., pyridyl, pyrimidinyl, pyrazole, imidizole, triazole, oxazole, isoxazole, thiazole, isothiazole, oxadiazole, thiadiazole, pyridazine, triazine, indole, indazole, benzoisoxazole, benzoxazole, benzoisothiazole, benzothiazole), substituted heteroaromatic, benzyl, substituted benzyl.
R 1 , R 2 , R 3 , R 4 , and R 5 individually can also represent —(CH 2 ) n —Ar, where n is preferably 1 to 3 and Ar is aromatic, substituted aromatic, heteroaromatic or substituted heteroaromatic. A and B individually can also represent —OR, —SR, —NR 2 (where R individually represents H, straight chain or branched chain lower alkoxy, aromatic, substituted aromatic, heteroaromatic, substituted heteroaromatic), halogen, aldehyde, carboxylic acid, —COOR, —CONHR, —CONR 2 , —OCONHR, —OCONR 2 , —NCONHR, —NCONR 2 , —SCONR 2 .
R 1 , R 2 , R 3 , R 4 , and R 5 can also be individually selected from —(CH 2 ) n —R′, (where R′ individually represents H, straight chain or branched chain lower alkoxy, aromatic, substituted aromatic, heteroaromatic, substituted heteroaromatic, halogen, aldehyde, carboxylic acid, —COOR, —CONHR, —CONR 2 , —OCONHR, —OCONR 2 , —NCONHR, —NCONR 2 , —SCONR 2 (where R individually represents H, straight chain or branched chain lower alkoxy, aromatic, substituted aromatic, heteroaromatic, substituted heteroaromatic).
In some embodiments, R 1 , R 2 , R 3 , R 4 , and R 5 are each independently selected from the group consisting of: H, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclo, heterocycloalkyl, heterocycloalkenyl, heterocycloalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, heteroarylalkynyl, alkoxy, halo, mercapto, azido, cyano, formyl, carboxylic acid, hydroxyl, nitro, acyl, aryloxy, alkylthio, amino, alkylamino, arylalkylamino, disubstituted amino, acylamino, acyloxy, ester, amide, sulfoxyl, sulfonyl, sulfonate, sulfonic acid, sulfonamide, urea, alkoxylacylamino, and aminoacyloxy.
10 . The method of claim 1 , wherein said active compound is selected from the group consisting of the compounds of Table 1 below
TABLE 1
and pharmaceutically acceptable salts or prodrugs thereof.
11 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.